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Case Report

Pulmonary alveolar microlithiasis diagnosed with
radiography, CT, and bone scintigraphy
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Pulmonary alveolar microlithiasis is rare disease characterized by accumulation of calcium
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phosphate microlithis in the alveoli. The pathogenesis relates to mutation in the gene
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SLC34A2 (solute carrier family 34 member 2) located on chromosome 4p15.2, which pro-
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duces a defective sodium-phosphate cotransporter in alveolar epithelial type-2 cells, mak-
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ing these cells unable to clear phosphorus released during recycling of surfactant [1].
© 2019 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
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In this article we report a case of pulmonary alveolar microlithiasis who presented with progressive dyspnea on exersion, and was diagnosed based on typical imaging findings,
obviating the need for lung biopsy.

Case presentation
A 67-year-old female presented with complaints of slowly
progressive shortness of breath on exertion and intermittent
dry cough for 7 years. She was a nonsmoking teacher with
no previously known pulmonary disease until 2012. She was
suspected to have an interstitial lung disease because of per-

sistent bilateral infiltrates on chest xray (CXR) (Fig. 1); however,
no further workup was done at that time. She denied fever or
hemoptysis. She was treated empirically multiple times in the
past with steroids with no improvement in her symptoms.
On physical examination, she was found to be tachypnic RR
24, and hypoxemic with SpO2 of 87% on room air improved to
92% on 2 L nasal O2 . Bilateral fine crackles were noted on auscultation with finger clubbing but no peripheral edema. Routine biochemistry including serum calcium and phosphorus
were normal.
A chest radiograph showed bilateral diffuse opacities
with sandstorm-like appearance suggestive of alveolar
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Fig. 1 – Chest X-ray showing diffuse bilateral infiltartes.

Fig. 4 – Technetium 99m -methylene diphosphonate
(Tc99m -MDP) showing diffuse radiotracer uptake.

on discharge and she was provided with 3 L nasal O2 after
assessed for home oxygen requirement.

Discussion

Fig. 2 – CT Scan of the chest without contrast showing
diffuse calcification with septal thickening.

Fig. 3 – CT Scan of the chest without contrast showing
diffuse ground glass attenuation with septal thickening.

microlithiasis. A chest CT showed diffuse calcifications in the
form of intra-alveolar microliths, calcified interlobular septa,
and diffuse ground-glass attenuation with septal thickening
(Figs. 2,3). To further confirm the diagnosis Technetium 99m methylene diphosphonate bone scan was done, and showed
diffuse radiotracer uptake (Fig. 4). These finding were deemed
adequate to establish a diagnosis of pulmonary alveolar
microlithiasis (PAM). Patient refused lung transplant referral

PAM is a rare autosomal recessive disease with high penetrance, in which concretions composed of calcium phosphate fill alveolar spaces, despite normal serum calcium and
phosphorus, and absence of any systemic disease of calcium
metabolism [2]. Over 1000 cases were reported worldwide especially in Mediterranean countries [3]. Several mutations in
the gene SLC34A2 on chromosome 4p15.2 are well known to
cause the disease [1,4].
This disease is typically diagnosed accidently between 30
and 50 years of age with no significant gender differences
found. The golden key in the diagnosis of this disease is
clinical-radiological dissociation as patients have less severity of symptoms compared to radiologic finding. Symptomatic
patients tend to have dyspnea, as well as a nonproductive
cough, mainly on exertion. Blood chemistry tests usually produce results within the normal range. Chest radiographic findings in PAM show diffuse, sandstorm-like infiltration, particularly in lower bases. Chest radiographs may include black
pleura sign seen as a strip of tangential peripheral lucency
underlying the ribs as compared to the adjacent diffusely
dense calcified lung. CT scan of the chest shows numerous
sandstorm-like calcifications throughout the lungs with subpleural and peribronchial distribution. Bone scintigraphy using technetium-99m labeled diphosphonate compounds have
affinity for calcification foci at soft tissue and can detect
early pulmonary calcification [5]. Histopathology is not always required and it is done by open lung or transbronchial
biopsy, showing intra-alveolar laminated calcium phosphate
concretions. There is no treatment available for this disease.
Thus, long-term oxygen therapy is required for hypoxemia
and chronic respiratory failure. In our patient lung biopsy was
not performed as she had typical findings on the bone scan.
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Supplementary materials
Supplementary material associated with this article can be
found, in the online version, at doi:10.1016/j.radcr.2019.03.032.
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